Michael Gendelman is currently an Account Manager at Exosome Diagnostics, where Michael is responsible for selling ExoDx, a genomic urine test for risk assessment for high-grade prostate cancer. Prior to this role, Michael worked as a Territory Manager at Boehringer Ingelheim, PersonalizeDx, Predicitve Biosciences, Urologix, and Medtronic, where Michael sold various medical products to healthcare professionals. with a background in Exercise Science and Physiology from Temple University.
This person is not in any offices